|
1
|
Vandamme N and Berx G: Melanoma cells
revive an embryonic transcriptional network to dictate phenotypic
heterogeneity. Front Oncol. 4:3522014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stewart BW and Wild CP: World Health
Organization World Cancer Report 2014. Chapter5.14; pp. 495–502.
2014
|
|
3
|
Jerant AF, Johnson JT, Sheridan CD and
Caffrey TJ: Early detection and treatment of skin cancer. Am Fam
Physician. 62:357–368. 375–376. 381–382. 2000.PubMed/NCBI
|
|
4
|
Halachmi S and Gilchrest BA: Update on
genetic events in the pathogenesis of melanoma. Cur Opin Oncol.
13:129–136. 2001. View Article : Google Scholar
|
|
5
|
Kanavy HE and Gerstenblith MR: Ultraviolet
radiation and melanoma. Semin Cutan Med Surg. 30:222–228. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jost LM; ESMO Guidelines Task Force: ESMO
minimum clinical recommendations for diagnosis, treatment and
follow-up of cutaneous malignant melanoma. Ann Oncol. 14:1012–1013.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Balch CM, Soong SJ, Gershenwald JE,
Thompson JF, Reintgen DS, Cascinelli N, Urist M, McMasters KM, Ross
MI, Kirkwood JM, et al: Prognostic factors analysis of 17,600
melanoma patients: Validation of the American joint committee on
cancer melanoma staging system. J Clin Oncol. 19:3622–3634.
2001.PubMed/NCBI
|
|
8
|
Sun XY, Nong J, Qin K, Lu H, Moniri MR,
Dai LJ and Warnock GL: MSC(TRAIL)-mediated HepG2 cell death in
direct and indirect co-cultures. Anticancer Res. 31:3705–3712.
2011.PubMed/NCBI
|
|
9
|
Loebinger MR and Janes SM: Stem cells as
vectors for anti-tumour therapy. Thorax. 65:362–369. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dai LJ, Moniri MR, Zeng ZR, Zhou JX, Rayat
J and Warnock GL: Potential implications of mesenchymal stem cells
in cancer therapy. Cancer Lett. 305:8–20. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang B, Wu X, Mao Y, Bao W, Gao L, Zhou P,
Xie R, Zhou L and Zhu J: Dual-targeted antitumor effects against
brainstem glioma by intravenous delivery of tumor necrosis
factor-related, apoptosis-inducing, ligand-engineered human
mesenchymal stem cells. Neurosurgery. 65:610–624. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ivanov DP, Parker TL, Walker DA, Alexander
C, Ashford MB, Gellert PR and Garnett MC: In vitro co-culture model
of medulloblastoma and human neural stem cells for drug delivery
assessment. J Biotechnol. 205:3–13. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mao ZG, Jiang CC, Yang F, Thorne RF,
Hersey P and Zhang XD: TRAIL-induced apoptosis of human melanoma
cells involves activation of caspase-4. Apoptosis. 15:1211–1222.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Friedenstein AJ, Deriglasova UF, Kulagina
NN, Panasuk AF, Rudakowa SF, Luriá EA and Ruadkow IA: Precursors
for fibroblasts in different populations of hematopoietic cells as
detected by the in vitro colony assay method. Exp Hematol. 2:83–92.
1974.PubMed/NCBI
|
|
15
|
Zuk PA, Zhu M, Mizuno H, Huang J, Futrell
JW, Katz AJ, Benhaim P, Lorenz HP and Hedrick MH: Multilineage
cells from human adipose tissue: Implications for cell-based
therapies. Tissue Eng. 7:211–228. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zuk PA, Zhu M, Ashjian P, De Ugarte DA,
Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P and Hedrick
MH: Human adipose tissue is a source of multipotent stem cells. Mol
Biol Cell. 13:4279–4295. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kern S, Eichler H, Stoeve J, Klüter H and
Bieback K: Comparative analysis of mesenchymal stem cells from bone
marrow, umbilical cord blood, or adipose tissue. Stem Cells.
24:1294–1301. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wiley SR, Schooley K, Smolak PJ, Din WS,
Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA,
et al: Identification and characterization of a new member of the
TNF family that induces apoptosis. Immunity. 3:673–682. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu GS: TRAIL as a target in anti-cancer
therapy. Cancer Lett. 285:1–5. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rosenecker J, Huth S and Rudolph C: Gene
therapy for cystic fibrosis lung disease: Current status and future
perspectives. Curr Opin Mol Ther. 8:439–445. 2006.PubMed/NCBI
|
|
21
|
Yamashita Y, Shimada M, Tanaka S,
Okamamoto M, Miyazaki J and Sugimachi K: Electroporation-mediated
tumor necrosis factor-related apoptosis-inducing ligand
(TRAIL)/Apo2L gene therapy for hepatocellular carcinoma. Hum Gene
Ther. 13:275–286. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ashkenazi A, Pai RC, Fong S, Leung S,
Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert
A, et al: Safety and antitumor activity of recombinant soluble Apo2
ligand. J Clin Invest. 104:155–162. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Grisendi G, Bussolari R, Cafarelli L,
Petak I, Rasini V, Veronesi E, De Santis G, Spano C, Tagliazzucchi
M, Barti-Juhasz H, et al: Adipose-derived mesenchymal stem cells as
stable source of tumor necrosis factor-related apoptosis-inducing
ligand delivery for cancer therapy. Cancer Res. 70:3718–3729. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dy GK and Adjei AA: Understanding,
recognizing, and managing toxicities of targeted anticancer
therapies. CA Cancer J Clin. 63:249–279. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zangi L, Lui KO, von Gise A, Ma Q, Ebina
W, Ptaszek LM, Später D, Xu H, Tabebordbar M, Gorbatov R, et al:
Modified mRNA directs the fate of heart progenitor cells and
induces vascular regeneration after myocardial infarction. Nat
Biotechnol. 31:898–907. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yoshioka N, Gros E, Li HR, Kumar S, Deacon
DC, Maron C, Muotri AR, Chi NC, Fu XD, Yu BD and Dowdy SF:
Efficient generation of human iPSCs by a synthetic self-replicative
RNA. Cell Stem Cell. 13:246–254. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Leonhardt C, Schwake G, Stögbauer TR,
Rappl S, Kuhr JT, Ligon TS and Rädler JO: Single-cell mRNA
transfection studies: Delivery, kinetics and statistics by numbers.
Nanomedicine. 10:679–688. 2014.
|
|
28
|
Stepinski J, Waddell C, Stolarski R,
Darzynkiewicz E and Rhoads RE: Synthesis and properties of mRNAs
containing the novel 'anti-reverse' cap analogs 7-methyl
(3′-O-methyl) GpppG and 7-methyl (3′-deoxy) GpppG. RNA.
7:1486–1495. 2001.PubMed/NCBI
|
